ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Travere Therapeutics Inc

Travere Therapeutics Inc (TVTX)

10.19
0.30
(3.03%)
Closed July 30 4:00PM
10.19
0.00
(0.00%)
After Hours: 6:56PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
10.19
Bid
10.01
Ask
10.85
Volume
1,316,418
9.91 Day's Range 10.72
5.12 52 Week Range 17.5699
Market Cap
Previous Close
9.89
Open
9.91
Last Trade
4
@
10.19
Last Trade Time
Financial Volume
$ 13,596,767
VWAP
10.3286
Average Volume (3m)
1,145,835
Shares Outstanding
76,129,018
Dividend Yield
-
PE Ratio
-6.96
Earnings Per Share (EPS)
-1.46
Revenue
145.24M
Net Profit
-111.4M

About Travere Therapeutics Inc

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Lewes, Delaware, USA
Founded
1970
Travere Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TVTX. The last closing price for Travere Therapeutics was $9.89. Over the last year, Travere Therapeutics shares have traded in a share price range of $ 5.12 to $ 17.5699.

Travere Therapeutics currently has 76,129,018 shares outstanding. The market capitalization of Travere Therapeutics is $752.92 million. Travere Therapeutics has a price to earnings ratio (PE ratio) of -6.96.

Travere Therapeutics (TVTX) Options Flow Summary

Overall Flow

Bearish

Net Premium

-119k

Calls / Puts

0.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

TVTX Latest News

Stanley Black & Decker Appoints Deborah K. Wintner Chief Human Resources Officer, Succeeding John T. Lucas

Stanley Black & Decker Appoints Deborah K. Wintner Chief Human Resources Officer, Succeeding John T. Lucas PR Newswire NEW BRITAIN, Conn., July 26, 2024 NEW BRITAIN, Conn., July 26, 2024...

Stanley Black & Decker Announces 3rd Quarter 2024 Dividend

Stanley Black & Decker Announces 3rd Quarter 2024 Dividend PR Newswire NEW BRITAIN, Conn., July 25, 2024 Board Of Directors Approves Quarterly Cash Dividend Increase To $0.82 Per Share NEW...

3 out of 4 Orlando-Based Tradespeople Say that Investment in Their Tools Was a Barrier to Beginning Their Career, DEWALT® Tool Talk Survey Finds

3 out of 4 Orlando-Based Tradespeople Say that Investment in Their Tools Was a Barrier to Beginning Their Career, DEWALT® Tool Talk Survey Finds PR Newswire TOWSON, Md., July 24, 2024 Amidst a...

Pepperoni Ranked Favorite Pizza Topping, According to New BLACK+DECKER Pizza Pulse Survey

Pepperoni Ranked Favorite Pizza Topping, According to New BLACK+DECKER Pizza Pulse Survey PR Newswire TOWSON, Md., July 16, 2024 Nearly three quarters of respondents say the ideal pizza night is...

STANLEY® National Survey Finds that Nearly Half of Residential Trade Pros Would Rather Go Without their Phone, Wallet or Keys than their Tape Measure

STANLEY® National Survey Finds that Nearly Half of Residential Trade Pros Would Rather Go Without their Phone, Wallet or Keys than their Tape Measure PR Newswire TOWSON, Md., July 10, 2024 In...

CRAFTSMAN®, Ace Hardware Foundation and Joe Gibbs Racing Rev up for the 18th Annual Racing for a Miracle Program, Supporting Children's Miracle Network (CMN) Hospitals

CRAFTSMAN®, Ace Hardware Foundation and Joe Gibbs Racing Rev up for the 18th Annual Racing for a Miracle Program, Supporting Children's Miracle Network (CMN) Hospitals PR Newswire CHICAGO, July...

Stanley Black & Decker Announces Release Date for Second Quarter 2024 Earnings

Stanley Black & Decker Announces Release Date for Second Quarter 2024 Earnings PR Newswire NEW BRITAIN, Conn., June 24, 2024 NEW BRITAIN, Conn., June 24, 2024 /PRNewswire/ -- Stanley Black...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.292.929292929299.910.729.416755079.7545873CS
4224.420024428.1910.727.7210316749.53249364CS
123.9262.51993620416.2710.726.0111458357.85098225CS
261.5718.21345707668.6210.725.1211842587.55499199CS
52-7.09-41.030092592617.2817.56995.1214146028.38645244CS
156-3.86-27.473309608514.0531.655.12111359916.20347069CS
260-14.96-59.483101391725.1533.08995.12102555316.85593714CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TWOU2U Inc
$ 2.70
(116.00%)
139.18M
LIPOLipella Pharmaceuticals Inc
$ 0.8576
(112.22%)
194.69M
NIPGNIP Group Inc
 16.50
(82.93%)
7.04M
TIVCTivic Health Systems Inc
$ 0.7049
(55.95%)
106.15M
ISPOInspirato Inc
$ 5.15
(47.99%)
6.24M
CGTXCognition Therapeutics Inc
$ 1.32
(-44.30%)
26.32M
GRIGRI Bio Inc
$ 0.8334
(-33.86%)
1.14M
CEROCERo Therapeutics Holdings Inc
$ 0.1817
(-29.02%)
8.28M
PRSTPresto Technologies Inc
$ 0.0499
(-26.51%)
29.32M
TGLTreasure Global Inc
$ 1.40
(-24.32%)
80.79k
NVDANVIDIA Corporation
$ 111.59
(-1.30%)
248.03M
LIPOLipella Pharmaceuticals Inc
$ 0.8576
(112.22%)
194.69M
SQQQProShares UltraPro Short QQQ
$ 9.05
(-0.55%)
152.03M
TWOU2U Inc
$ 2.70
(116.00%)
139.18M
TSLATesla Inc
$ 232.10
(5.60%)
129.2M

Your Recent History

Delayed Upgrade Clock